Font Size: a A A
Keyword [HFrEF]
Result: 21 - 40 | Page: 2 of 3
21. Clinical Application of Acoustic Cardiography
22. Clinical Study On The Treatment And Prevention Of Heart Failure With HPSP
23. Heart Failure Blood Pressure Management And Pharmacoeconomics Research
24. Pulmonary Arterial Pressure And Right Heart Structural Changes Of Heart Failure With Preserved Or Reduced Ejection Fraction
25. Comparative Analysis Of The Clinical Efficacy Of Sacubitril Valsartan And Enalapril In Patients With Heart Failure With Reduced Ejection Fraction
26. Effect Of Application Of Esmolol Early On Heart Rate And Clinical Benefit Of HFrEF Patients With T2DM
27. Analysis Of Factors Affecting The Recovery Of Ejection Fraction In Patients With Chronic HFrEF And HFmrEF
28. Study On The Use And Efficacy Of Sacubatril / Valsartan Sodium Tablets In Patients With HFrEF In Dali
29. Short-term Efficacy Of Sacubitril/valsartan In Patients With Two Different Etiologies Of HFrEF
30. The Diagnostic Value And Correlation Of Plasma Deubiquitinase BRCC36 Level In Heart Failure
31. Effect Of Loading Treatment With Yangxin’s Tablets On Cardiac Function And Quality Of Life In Patients With HFrEF (Qi Deficiency And Blood Stasis Type)
32. Clinical Observation On Curative Effects And Safety Of Sacubitril/valsartan Dealing With Different Types Of Chronic Heart Failure
33. Clinical Observation On The Treatment Of Patients With HFrEF Of Heart-kidney Yang Deficiency By Shacubatril Valsartan Sodium Tablets Combined With Shenqi Jianxin Prescription
34. A Retrospective Study Of Guideline-Directed Medical Therapy In The Outpatient With Chronic HFrEF And Their Tolerability Of Treatment With ARNI
35. Clinical Efficacy Of Sacubitril/Valsartan In Dialated Cardiomyopathy With HFrEF
36. Study On Weakness Of Non-HFrEF Patients In TCM Syndrome Elements Distribution And The Analysis On The Correlation Between Weakness Of Non-HFrEF Patients And IL-6,hs-CRP And FT3
37. Study On The Clinical Efficacy Of HFrEF Patients With Renal Insufficiency In Dapagliflozin
38. Correlation Of Plasma Gal-3、GDF-15、ANP、sST-2 Concentrations And Tei Index In Patients Dilated Cardiomyopathy Combined With HFrEF
39. Effect Of Sacubitril/valsartan Sodium On SST2 And Inflammatory Factors And Prognosis Evaluation In Patients With HfrEF
40. Analysis Of Clinical Factors For Improvement Of Ejection Fraction In AMI Patients Combined With HFrEF
  <<First  <Prev  Next>  Last>>  Jump to